Medicine’s House of Cards – What Happens When We’ve Got It All Wrong

I have to admit, the randomized, double-blind, placebo-controlled trial still holds a special place in my heart even after I have spent the past half-decade immersed in the shortcomings of our current data collection model.  As I discuss here, I understand now, the role of industry bias in publication of studies, Continue reading